Dietary interventions for multiple sclerosis (Q24246218)

3

0 references

author name string

Mariangela Farinotti

1

0 references

Silvana Simi

2

0 references

Nicola McDowell

4

0 references

Lorenzo Brait

5

0 references

Daniela Lupo

Cochrane Database of Systematic Reviews

6

0 references

publication date

24 January 2007

0 references

published in

0 references

cites work

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Double-blind Trial of Linoleate Supplementation of the Diet in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Alfacalcidol treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Polyunsaturated fatty acids and colchicine in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Treatment and management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Letter: Linoleic acid in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Review of MS patient survival on a Swank low saturated fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Lipoic acid in multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Diet and the geographical distribution of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Current Complementary and Alternative Therapies for Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

The role of vitamin D in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Environmental risk factors in MS: a case-control study in Moscow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Small-bowel abnormalities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

The food pattern in geographical relation to the risk of multiple sclerosis in the Mediterranean and Near East region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Diet and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Vitamin B12, demyelination, remyelination and repair in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Multiple sclerosis--one manifestation of neurobrucellosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Multiple sclerosis, latitude and dietary fat: is pork the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Multiple sclerosis and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Risk factors of multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

Multiple Sclerosis: Twenty Years on Low Fat Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Multiple sclerosis and nutrition

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Double-blind Trial of Linoleic Acid in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Vitamin B12 metabolism in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Treatment of multiple sclerosis with low-fat diet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Treatment of multiple sclerosis with low-fat diet; results of five and one-half years' experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Prevention of corticosteroid-induced osteoporosis by alfacalcidol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Long-term treatment of multiple sclerosis with corticotrophin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Effect of gamma-linolenate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Is there a role for saturated and long-chain fatty acids in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

How saturated fats may be a causative factor in multiple sclerosis and other diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Lipids and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Complementary and Alternative Medicine in Multiple Sclerosis: Survey of Licensed Naturopaths

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Multiple sclerosis: the lipid relationship

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

The influence of low-fat diet on blood lipid levels in health and in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Multiple sclerosis and macrocytosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Efficacy of cranberry juice and ascorbic acid in acidifying the urine in multiple sclerosis subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

MULTIPLE SCLEROSIS AND GEOGRAPHY. NEW INTERPRETATION OF EPIDEMIOLOGICAL OBSERVATIONS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Role of food allergy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Utilization of unconventional treatments by persons with MS: is it alternative or complementary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021

Treatment of multiple sclerosis with low-fat diet: result of seven years' experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB2

7 January 2021